Drug
natalizumab-sztn
Marketed as TYRUKO.
Generic name
natalizumab-sztn
Brand names
TYRUKO
First FDA approval
2023-08-24
FDA approval history
| FDA ID | Brand | Approval date | Manufacturer |
|---|---|---|---|
| BLA761322 | TYRUKO | 2023-08-24 | SANDOZ INC |
Manufacturers
SANDOZ INC
Frequently asked questions
When was natalizumab-sztn FDA approved?
Earliest FDA approval on record: 2023-08-24.
What brand names are sold as natalizumab-sztn?
TYRUKO.
Sources
Appeal a natalizumab-sztn denial
Upload your denial — DenialHelp drafts a physician-ready appeal letter in five minutes with the right clinical guideline and federal regulation cited. $39 first-level, money back if we can't draft a strong appeal.
Get started →Contact: hello@denialhelp.com